Reason: Lack of Assurance of Sterility; potential for mold contamination
Distributed: Press States Nationwide. Distribution List indicates the following: DE, FL, IL, IN, ME, MI, NJ, PA, TX, and VAReason: Non-Sterility; mold contamination
Distributed: Press States Nationwide. Distribution List indicates the following: DE, FL, IL, IN, ME, MI, NJ, PA, TX, and VAReason: Non-Sterility: one or more components of the kit have been found to be contaminated with yeast.
Distributed: Nationwide and Military and Government ConsigneesReason: Presence of Particulate Matter; particulate found in retain samples
Distributed: Nationwide & Bahamas, Barbados, Bermuda, JapanReason: Failed Stability Specifications: Out of specification results for particle size were obtained at the 60 month test point.
Distributed: NY, CAReason: Crystallization: Potential to exhibit precipitation/crystallization in IV bag or IV line upon reconstitution.
Distributed: NationwideReason: Contraceptive Tablets out of Sequence: A placebo tablet was found in a row of active tablets.
Distributed: Distributed to one consignee in Indiana. No foreign, government, VA, or military consignees.Reason: Subpotent Drug; 15-month stability test station
Distributed: Nationwide and Puerto RicoReason: Discoloration: This recall is being carried out due to an orange to brown discolored Amoxicillin powder on the inner foil seal of the bottles. This is an expansion of RES 65050.
Distributed: NationwideReason: Failed Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.
Distributed: Nationwide